Hepatitis B Vaccine Antibody Response and the Risk of Clinical AIDS or Death
Michael L. Landrum(San Antonio Military Medical Center), Brian K. Agan(Henry M. Jackson Foundation), Amy Weintrob, Nancy F. Crum‐Cianflone(Henry M. Jackson Foundation), Helen Chun, Katherine Huppler Hullsiek(University of Minnesota), Robert J. O’Connell(Walter Reed Army Institute of Research), Jason F. Okulicz(Gilead Sciences (United States)), Anuradha Ganesan(Walter Reed National Military Medical Center), Tahaniyat Lalani(Henry M. Jackson Foundation)
Cited by 12
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176